Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by wizzdumbon Jul 05, 2023 9:18am
98 Views
Post# 35527049

RE:RE:RE:The old cliche ……

RE:RE:RE:The old cliche ……Yes, it is. Many other countries will be doing the same thing coordinated at the national level. They like to copy each other, since the Dutch have already done the heavy lifting others may just copy, although surprised these are liquid versus swab. The margins on swab are better as I recall along with other advantages. 
<< Previous
Bullboard Posts
Next >>